0000000000847337

AUTHOR

Kamran Zaheer

0000-0002-0253-3674

showing 2 related works from this author

Formulation strategy towards minimizing viscosity mediated negative food effect on disintegration and dissolution of immediate release tablets.

2017

Food induced viscosity can delay disintegration and subsequent release of API from solid dosage form which may lead to severe reduction in the bioavailability of BCS type III compounds. Formulations of such tablets need to be optimized in view of this postprandial viscosity factor. In this study, three super disintegrants, croscarmellose sodium (CCS), cross-linked polyvinylpolypyrrolidone (CPD), and sodium starch glycolate (SSG) were assessed for their efficiency under simulated fed state. Tablets containing these disintegrants were compressed at 10 and 30 KN, while taking lactose as a soluble filler. In addition to other compendial tests, disintegration force of these formulations was meas…

Chemistry PharmaceuticalPharmaceutical ScienceLactose02 engineering and technology030226 pharmacology & pharmacyDosage formExcipients03 medical and health sciencesViscosity0302 clinical medicineDrug DiscoverySodium Starch GlycolateImmediate releaseDissolutionPharmacologyFOOD EFFECTChemistryViscosityOrganic Chemistryfood and beveragesPovidoneStarch021001 nanoscience & nanotechnologyBioavailabilityChemical engineeringSolubilityFoodCarboxymethylcellulose Sodium0210 nano-technologyFederal stateTabletsDrug development and industrial pharmacy
researchProduct

Designing robust immediate release tablet formulations avoiding food effects for BCS class 3 drugs

2019

Abstract Food induced viscosity in the gastrointestinal tract is reported to reduce the bioavailability of tablets containing BCS class 3 drugs, mainly by retarding their disintegration and dissolution of the active pharmaceutical ingredient. The role of formulation factors in minimizing this negative food effect is largely unknown. Combinations of disintegrants were studied together with soluble and insoluble fillers and trospium chloride as model drug substance. Different batches of tablets were compressed at 10 kN and 30 kN, by incorporating different combinations of croscarmellose sodium (CSS), cross-linked (CPD) and sodium starch glycolate (SSG) at low level i.e, 2% + 2% and high level…

NortropanesChemistry PharmaceuticalDrug CompoundingPharmaceutical Science02 engineering and technologyBenzilates030226 pharmacology & pharmacyExcipientsFood-Drug Interactions03 medical and health sciencesViscositychemistry.chemical_compound0302 clinical medicineFood scienceSolubilityLactoseDissolutionActive ingredientCroscarmellose sodiumViscosityChemistryGeneral Medicine021001 nanoscience & nanotechnologyBioavailabilityMicrocrystalline celluloseDrug LiberationSolubilityDrug Design0210 nano-technologyTabletsBiotechnologyEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct